Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CellTypeAI: Automated cell identification for scRNA-seq using local generative-AI

Created on 06 Mar 2026

Authors

Daw, R. H., Deijnen, H. R., Rattray, M., Grainger, J. R.

Abstract

Single-cell RNA sequencing (scRNA-seq) cell annotation techniques rely on the matching of known defining marker genes to a given cell population. However, these methods may lack robustness to dynamic fluctuations in cell marker expression between patients, samples and pathologies. The advent of easy-to-implement predictive technologies, like generative-AI (gen-AI), has facilitated the introduction of computational workflows that improve otherwise inaccurate context-dependent cell type annotation. Here, we introduce CellTypeAI, a streamlined, scalable program developed for tissue context-dependent cell annotation of scRNA-seq datasets using modern gen-AI models, enhanced by retrieval augmented generation methods. Our implementation builds upon local gen-AI hosting technologies and directly integrates into scRNA-seq analysis pipelines. We show that CellTypeAI provides improved annotation accuracy compared to current conventional annotation methods and nascent cloud-based gen-AI approaches. As CellTypeAI leverages locally-run AI models, it can be applied to sensitive datasets, unlike approaches utilising online gen-AI tools such as ChatGPT, DeepSeek, or Claude. CellTypeAI presents a novel solution for tissue-specific cell type identification, overcoming traditional marker-based limitations via locally-deployed generative-AI models.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 06 Mar 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement